Ok Biotech Co Ltd (TW:4155) — Market Cap & Net Worth
Market Cap & Net Worth: Ok Biotech Co Ltd (4155)
Ok Biotech Co Ltd (TW:4155) has a market capitalization of $68.03 Million (NT$2.16 Billion) as of June 19, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #20780 globally and #1272 in its home market, demonstrating a -2.24% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ok Biotech Co Ltd's stock price NT$15.30 by its total outstanding shares 141124000 (141.12 Million). Review how much debt does Ok Biotech Co Ltd carry to assess the company's total debt and financial obligations.
Ok Biotech Co Ltd Market Cap History: 2015 to 2026
Ok Biotech Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $91.39 Million to $68.03 Million (0.23% CAGR).
Ok Biotech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ok Biotech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Ok Biotech Co Ltd's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.78x
Ok Biotech Co Ltd's market cap is 0.78 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $81.21 Million | $1.04 Billion | $85.20 Million | 0.08x | 0.95x |
| 2017 | $88.67 Million | $1.23 Billion | $126.81 Million | 0.07x | 0.70x |
| 2018 | $76.27 Million | $1.12 Billion | $161.36 Million | 0.07x | 0.47x |
| 2019 | $110.91 Million | $1.24 Billion | $125.76 Million | 0.09x | 0.88x |
| 2020 | $93.49 Million | $1.48 Billion | $129.73 Million | 0.06x | 0.72x |
| 2021 | $85.47 Million | $1.26 Billion | $31.42 Million | 0.07x | 2.72x |
| 2022 | $105.27 Million | $1.48 Billion | $143.46 Million | 0.07x | 0.73x |
| 2023 | $110.22 Million | $1.19 Billion | $2.95 Million | 0.09x | 37.39x |
| 2024 | $90.92 Million | $1.67 Billion | $93.97 Million | 0.05x | 0.97x |
| 2025 | $64.47 Million | $1.56 Billion | $82.45 Million | 0.04x | 0.78x |
Competitor Companies of 4155 by Market Capitalization
Companies near Ok Biotech Co Ltd in the global market cap rankings as of June 19, 2026.
Key companies related to Ok Biotech Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
Ok Biotech Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Ok Biotech Co Ltd's market cap moved from $91.39 Million to $ 68.03 Million, with a yearly change of 0.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$68.03 Million | +5.52% |
| 2025 | NT$64.47 Million | -29.10% |
| 2024 | NT$90.92 Million | -17.51% |
| 2023 | NT$110.22 Million | +4.70% |
| 2022 | NT$105.27 Million | +23.16% |
| 2021 | NT$85.47 Million | -8.58% |
| 2020 | NT$93.49 Million | -15.71% |
| 2019 | NT$110.91 Million | +45.41% |
| 2018 | NT$76.27 Million | -13.98% |
| 2017 | NT$88.67 Million | +9.19% |
| 2016 | NT$81.21 Million | -11.14% |
| 2015 | NT$91.39 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Ok Biotech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $68.03 Million USD |
| MoneyControl | $68.03 Million USD |
| MarketWatch | $68.03 Million USD |
| marketcap.company | $68.03 Million USD |
| Reuters | $68.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ok Biotech Co Ltd
OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-f… Read more